SCOTTSDALE, Ariz., Dec. 11, 2018 /PRNewswire/ -- Research from one of Scottsdale-based ArizonaBreast Cancer Specialists' founders (a division of Arizona Center for Cancer Care), Robert Kuske, MD, was presented at the 2018 San Antonio Breast Cancer Symposium held December 4-8. The
According to Dr. Kuske, "This study will change the practice of medicine worldwide because there are fewer long-term side effects and much greater convenience with this 5-day treatment of breast cancer."
A radiation oncologist passionate about helping women with breast cancer, Dr. Kuske pioneered "accelerated partial breast irradiation," known as Brachytherapy, a five-day alternative to the conventional six weeks of external beam whole breast irradiation in select early-stage breast cancer. Brachytherapy also spares the lung and heart from radiation exposure. He is a leader of the important 4300 patient phase III trial through the National Cancer Institute. He is recognized for his work that allows women who have been augmented with breast implants to be successfully treated with lumpectomy and 5-day radiation without hardening of the implants. Dr. Kuske is one of only a dozen radiation doctors in the U.S. who restrict their practice to breast cancer and publish extensively in medical literature. He was honored as the top medical researcher in the Valley.
For more information, press only:
Jenny Martin 414-378-8703 Jenny.firstname.lastname@example.org
For more information on Product:
View original content:http://www.prnewswire.com/news-releases/research-from-scottsdale-radiation-oncologist-dr-robert-kuske-presents-important-data-in-stage-0-1--or-2-breast-cancer-at-the-2018-san-antonio-breast-cancer-symposium-300763561.html
SOURCE Arizona Breast Cancer Specialists
Subscribe to our Free Newsletters!